<table><tr><td rowspan="3">510(k) Owner:</td><td rowspan="3">Contact:</td><td>Alfa Wassermann Diagnostic Technologies, LLC</td><td></td></tr><tr><td>4 Henderson Drive West Caldwell, NJ 07006</td><td></td></tr><tr><td>Hyman Katz, Ph.D.</td><td></td></tr><tr><td>Date Summary</td><td>Fax: 973-852-0237 April 8, 2013</td><td>Phone: 973-852-0158</td><td></td></tr><tr><td>Prepared: Device:</td><td colspan="3">Trade Name: ACE Alera Clinical Chemistry System</td></tr><tr><td></td><td colspan="3">Classification:</td></tr><tr><td rowspan="9"></td><td colspan="3">Class 1 Common/Classification Name:</td></tr><tr><td colspan="3">Analyzer, Chemistry (Photometric, Discrete), For</td></tr><tr><td colspan="3">Clinical Use</td></tr><tr><td colspan="3">(21 C.F.R. § 862.2160)</td></tr><tr><td colspan="3">Product Code JJE</td></tr><tr><td colspan="3"></td></tr><tr><td colspan="3"></td></tr><tr><td colspan="3">ACE Glucose Reagent</td></tr><tr><td colspan="3">Trade Name: Class 2</td></tr><tr><td colspan="3">Classification: Common/Classification Name:</td></tr><tr><td colspan="3">Hexokinase, Glucose (21 C.F.R. § 862.1345)</td></tr><tr><td colspan="3">Product Code CFR</td></tr><tr><td colspan="3"></td></tr><tr><td colspan="3"></td></tr><tr><td colspan="3">Trade Name: ACE Ion Selective Electrode (ISE) Module</td></tr><tr><td colspan="3">Classification: Class 2</td></tr><tr><td colspan="3">Common/Classification Name: Electrode, Ion Specific, Sodium, Potassium,</td></tr><tr><td colspan="3">Chloride (21 C.F.R. § 862.1665, 862.1600, 862.1170)</td></tr><tr><td colspan="3">Product Codes JGS, CEM, CGZ</td></tr><tr><td colspan="3">Predicate Manufacturer for reagent system predicates:</td></tr><tr><td colspan="3">Devices:</td></tr><tr><td colspan="3">Alfa Wassermann ACE plus ISE/Clinical Chemistry System</td></tr><tr><td colspan="3"></td></tr><tr><td colspan="3">ACE Reagents (K930140, K933862)</td></tr></table>

<table><tr><td>Device Descriptions: nm/378 nm. The ACE Ion Selective Electrode (ISE) Module, as part of the ACE, ACE Alera, and ACE Axcel Clinical Chemistry Systems, uses a potentiometric method via ion-specific electrodes to simultaneously measure sodium, potassium and chloride in undiluted serum. Ion-specific membranes measure the difference in ionic concentrations between an inner electrolyte solution and the sample. The connection of the amplifier and ground (reference electrode) to the ion selective electrode forms the measuring system.</td><td>The ACE Alera Clinical Chemistry System is an automated, discrete, bench-top, random access analyzer that is intended for in vitro diagnostic use in the quantitative determination of general chemistry assays for clinical use in physician office laboratories or clinical laboratories. The ACE Alera Clinical Chemistry System consists of a bench-top analyzer and an internal computer. The bench-top analyzer includes a single pipettor (syringe module/fluid arm/probe), a temperature-controlled reagent compartment, a reaction wheel and a holographic diffraction grating spectrophotometer. In the ACE Glucose Reagent assay, glucose in serum or heparin plasma reacts with adenosine triphosphate in the presence of hexokinase and magnesium with the formation of glucose-6-phosphate and adenosine diphosphate. Glucose-6-phosphate dehydrogenase catalyzes the oxidation of glucose-6-phosphate with NAD* to form 6- phosphogluconate and NADH. NADH absorbs strongly at 340 nm, whereas NAD* does not. The total amount of NADH formed is proportional to the concentration of glucose in the sample. The increase in absorbance is measured bichromatically at 340</td></tr><tr><td>Intended Use: Indications for Use:</td><td>A two-point calibration utilizes ACE CAL A and CAL B undiluted ISE Calibration Solutions with precisely known ion concentrations. The measured voltage difference of the sample and the CAL A and CAL B solutions determines the ion concentration in the sample on the ACE, ACE Alera, and ACE Axcel Clinical Chemistry Systems. The ACE Alera Clinical Chemistry System is an automated, discrete, bench-top, random access analyzer that is intended for in vitro diagnostic use in the quantitative measurement of general chemistry assays, such as glucose, sodium, potassium, and chloride, for clinical use in physician office laboratories or clinical laboratories.</td></tr><tr><td>electrolyte imbalance. Potassium measurements are used to monitor electrolyte balance in the diagnosis and treatment of disease conditions characterized by low or high blood potassium levels. Chloride measurements are used in the diagnosis and treatment of electrolyte and metabolic disorders such as cystic fibrosis and diabetic acidosis.</td><td>ACE Glucose Reagent is intended for the quantitative determination of glucose in serum and lithium heparin plasma using the ACE, ACE Alera; and ACE Axcel Clinical Chemistry Systems. Glucose measurements are used in the diagnosis and treatment of carbohydrate metabolism disorders including diabetes mellitus, neonatal hypoglycemia and idiopathic hypoglycemia, and of pancreatic islet cell carcinoma. This test is intended for use in clinical laboratories and physician office laboratories. For in vitro diagnostic use only. 7  145* The ACE Ion Selective Electrode (ISE) module on the ACE, ACE Alera, and ACE Axcel Clinical Chemistry Systems is used to measure concentrations of sodium, potassium, and chloride in undiluted serum and lithium heparin plasma. Sodium measurements are used in the diagnosis and treatment of diseases involving</td></tr><tr><td>Technological Characteristics:</td><td>For in vitro diagnostic use only. The ACE Glucose Reagent consists of a single reagent bottle. The reagent contains nicotinamide adenine dinucleotide (NAD), adenosine 5'-triphosphate (ATP), magnesium, hexokinase and glucose-6-phosphate dehydrogenase. ACE ISE Module CAL A and CAL B Undiluted ISE Calibration Solution contain known levels of sodium, potassium and chloride.</td></tr></table>

:\* Device.. Comparison with Predicate   
Comparison of similarities and differences:   

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Candidate Device</td><td rowspan=1 colspan=1>Predicate DeviceK1 13253 (ACE Axcel System)</td></tr><tr><td rowspan=1 colspan=1>Intended Use/Indications forUse</td><td rowspan=1 colspan=1>Clinical chemistry analyzer intendedfor the quantitative measurements ofgeneral chemistry assays. For use inclinical laboratories or physicianoffice laboratories.</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>InstrumentPlatform</td><td rowspan=1 colspan=1>ACE Alera ClinicalChemistry System</td><td rowspan=1 colspan=1>ACE Axcel ClinicalChemistry System</td></tr><tr><td rowspan=1 colspan=1>Method ofmeasurements</td><td rowspan=1 colspan=1>Potentiometric (ISE) andphotometric chemistries</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Calibration</td><td rowspan=1 colspan=1>same</td><td rowspan=1 colspan=1>Automatic</td></tr><tr><td rowspan=1 colspan=1>CalibrationStability</td><td rowspan=1 colspan=1>same</td><td rowspan=1 colspan=1>3 hrs. STAT READY, as required after3 hrs. STANDBY. When solution lotnumbers are changed, new electrodesare installed, major service isperformed or a control shift warrants</td></tr><tr><td rowspan=1 colspan=1>Sample Volume</td><td rowspan=1 colspan=1>same</td><td rowspan=1 colspan=1>156μL. .</td></tr><tr><td rowspan=1 colspan=1>ISE Type</td><td rowspan=1 colspan=1>same</td><td rowspan=1 colspan=1>Direct (undiluted)</td></tr></table>

# ACE Ion Selective Electrode (ISE) Module

Comparison of similarities and differences:

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Candidate Device</td><td rowspan=1 colspan=1>Predicate DeviceACE Clinical Chemistry SysteWith ISE (k933862)</td></tr><tr><td rowspan=1 colspan=1>IntendedUse/Indicationsfor Use</td><td rowspan=1 colspan=1>For the quantitativemeasurements of sodium,potassium, and chloride inhuman serum and lithiumheparin plasma</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Method</td><td rowspan=1 colspan=1>Potentiometric: lon-selectiveelectrode</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Sample Type</td><td rowspan=1 colspan=1>Serum and lithium heparinplasma</td><td rowspan=1 colspan=1>Serum</td></tr><tr><td rowspan=1 colspan=1>ExpectedValues</td><td rowspan=1 colspan=1>Na: 136-145 mmol/LK: 3.5-5.1 mmol/LCl: 98- 107 mmol/L</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Measuringrange</td><td rowspan=1 colspan=1>Na 40-205 mmol/LK 1.5-15 mmol/LCl 50-200 mmol/L</td><td rowspan=1 colspan=1>Same</td></tr></table>

# ACE Glucose Reagent

Comparison of similarities and differences:

!   

<table><tr><td rowspan=1 colspan=1>GLUCOSE</td><td rowspan=1 colspan=1>Candidate Device</td><td rowspan=1 colspan=1>Predicate Devicek930104(ACE Glucose Reagent)</td></tr><tr><td rowspan=1 colspan=1>IntendedUse/Indicationsfor Use</td><td rowspan=1 colspan=1>For the quantitative measurement ofglucose in human serum and lithiumheparin plasma</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Method</td><td rowspan=1 colspan=1>Photometric</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Sample Type</td><td rowspan=1 colspan=1>Serum and lithium heparinplasma</td><td rowspan=1 colspan=1>Serum</td></tr><tr><td rowspan=1 colspan=1>Expected value</td><td rowspan=1 colspan=1>70-105 mg/dL</td><td rowspan=1 colspan=1>Serum</td></tr><tr><td rowspan=1 colspan=1>Measuring range</td><td rowspan=1 colspan=1>4-750 mg/dL</td><td rowspan=1 colspan=1>3-750 mg/dL</td></tr></table>

<table><tr><td rowspan=1 colspan=7>Precision (SD, %CV)                   </td></tr><tr><td rowspan=1 colspan=1>Glucose</td><td rowspan=1 colspan=1>ACE</td><td rowspan=2 colspan=1>Within-Run</td><td rowspan=2 colspan=1>Total</td><td rowspan=1 colspan=1>Alera</td><td rowspan=2 colspan=1>Within-Run</td><td rowspan=2 colspan=1>Total</td></tr><tr><td rowspan=1 colspan=1>mg/dL</td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>Mean</td></tr><tr><td rowspan=1 colspan=1>Serum Low</td><td rowspan=1 colspan=1>58</td><td rowspan=1 colspan=1>0.6, 1.1%</td><td rowspan=1 colspan=1>0.8, 1.4%</td><td rowspan=1 colspan=1>62</td><td rowspan=1 colspan=1>0.6, 0.9%</td><td rowspan=1 colspan=1>0.8, 1.3%</td></tr><tr><td rowspan=1 colspan=1>Serum Mid</td><td rowspan=1 colspan=1>158</td><td rowspan=1 colspan=1>1.4, 0.9%</td><td rowspan=1 colspan=1>2.6, 1.7%</td><td rowspan=1 colspan=1>121</td><td rowspan=1 colspan=1>1.2, 1.0%</td><td rowspan=1 colspan=1>1.5, 1.3%</td></tr><tr><td rowspan=1 colspan=1>Serum High</td><td rowspan=1 colspan=1>273</td><td rowspan=1 colspan=1>2.5, 0.9%</td><td rowspan=1 colspan=1>3.1, 1.2%</td><td rowspan=1 colspan=1>366</td><td rowspan=1 colspan=1>6.4, 1.8%</td><td rowspan=1 colspan=1>6.9, 1.9%</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Sodium</td><td rowspan=1 colspan=1>ACE</td><td rowspan=2 colspan=1>Within-Run</td><td rowspan=2 colspan=1>Total</td><td rowspan=1 colspan=1>Alera</td><td rowspan=2 colspan=1>Within-Run</td><td rowspan=2 colspan=1>Total</td></tr><tr><td rowspan=1 colspan=1>mmol/L</td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>Mean</td></tr><tr><td rowspan=1 colspan=1>Serum Low</td><td rowspan=1 colspan=1>111.4</td><td rowspan=1 colspan=1>0.63, 0.6%</td><td rowspan=1 colspan=1>0.93, 0.8%</td><td rowspan=1 colspan=1>111.2</td><td rowspan=1 colspan=1>0.59, 0.5%</td><td rowspan=1 colspan=1>0.93, 0.8%</td></tr><tr><td rowspan=1 colspan=1>Serum Mid</td><td rowspan=1 colspan=1>139.1</td><td rowspan=1 colspan=1>1.14, 0.8%</td><td rowspan=1 colspan=1>1.14, 0.8%</td><td rowspan=1 colspan=1>139.0</td><td rowspan=1 colspan=1>0.80, 0.6%</td><td rowspan=1 colspan=1>0.87, 0.6%</td></tr><tr><td rowspan=1 colspan=1>Serum High</td><td rowspan=1 colspan=1>159.7</td><td rowspan=1 colspan=1>0.56, 0.4%</td><td rowspan=1 colspan=1>0.74, 0.5%</td><td rowspan=1 colspan=1>159.9</td><td rowspan=1 colspan=1>0.38, 0.2%</td><td rowspan=1 colspan=1>0.90, 0.6%</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>$a$</td><td rowspan=1 colspan=1>¥</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Potassium</td><td rowspan=1 colspan=1>ACE</td><td rowspan=2 colspan=1>Within-Run</td><td rowspan=2 colspan=1>Total</td><td rowspan=1 colspan=1>Alera</td><td rowspan=2 colspan=1>Within-Run</td><td rowspan=2 colspan=1>Total</td></tr><tr><td rowspan=1 colspan=1>mmol/L</td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>Mean</td></tr><tr><td rowspan=1 colspan=1>Serum Low</td><td rowspan=1 colspan=1>2.1</td><td rowspan=1 colspan=1>0.02, 1.0%</td><td rowspan=1 colspan=1>0.04, 1.6%</td><td rowspan=1 colspan=1>2.2</td><td rowspan=1 colspan=1>0.04, 1.6%</td><td rowspan=1 colspan=1>0.05, 2.4%</td></tr><tr><td rowspan=1 colspan=1>Serum Mid</td><td rowspan=1 colspan=1>3.9</td><td rowspan=1 colspan=1>0.08, 2.0%</td><td rowspan=1 colspan=1>0.08, 2.0%</td><td rowspan=1 colspan=1>4.0</td><td rowspan=1 colspan=1>0.07, 1.8%</td><td rowspan=1 colspan=1>0.07, 1.8%</td></tr><tr><td rowspan=1 colspan=1>Serum High</td><td rowspan=1 colspan=1>7.9</td><td rowspan=1 colspan=1>0.07, 0.9%</td><td rowspan=1 colspan=1>0.09, 1.2%</td><td rowspan=1 colspan=1>7.9  -</td><td rowspan=1 colspan=1>0.07, 0.9%</td><td rowspan=1 colspan=1>0.11, 1.4%</td></tr><tr><td rowspan=1 colspan=1>    &quot;</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Chloride</td><td rowspan=1 colspan=1>ACE</td><td rowspan=2 colspan=1>Within-. Run</td><td rowspan=2 colspan=1>Total</td><td rowspan=1 colspan=1>Alera</td><td rowspan=2 colspan=1>Within-Run</td><td rowspan=2 colspan=1>Total</td></tr><tr><td rowspan=1 colspan=1>mmol/L</td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>Mean</td></tr><tr><td rowspan=1 colspan=1>Serum Low</td><td rowspan=1 colspan=1>74.7</td><td rowspan=1 colspan=1>0.50, 0.7%</td><td rowspan=1 colspan=1>1.00, 1.3%</td><td rowspan=1 colspan=1>75.0</td><td rowspan=1 colspan=1>0.80, 1.1%</td><td rowspan=1 colspan=1>1.50, 2.0%</td></tr><tr><td rowspan=1 colspan=1>Serum Mid</td><td rowspan=1 colspan=1>99.1</td><td rowspan=1 colspan=1>0.70, 0.7%</td><td rowspan=1 colspan=1>0.80, 0.8%</td><td rowspan=1 colspan=1>99.2</td><td rowspan=1 colspan=1>0.80, 0.8%</td><td rowspan=1 colspan=1>0.90, 0.9%</td></tr><tr><td rowspan=1 colspan=1>Serum High</td><td rowspan=1 colspan=1>119.3</td><td rowspan=1 colspan=1>0.50, 0.4%</td><td rowspan=1 colspan=1>0.80, 0.7%</td><td rowspan=1 colspan=1>119.3</td><td rowspan=1 colspan=1>0.50, 0.4%</td><td rowspan=1 colspan=1>1,10, 0.9%</td></tr></table>

# POL Precision

<table><tr><td colspan="2" rowspan="1">Glucose</td><td colspan="3" rowspan="1">ACESD (mg/dL) or %CV</td><td colspan="3" rowspan="1">ACE AleraSD (mg/dL) or %CV</td></tr><tr><td colspan="1" rowspan="1">Lab</td><td colspan="1" rowspan="1">Sample</td><td colspan="1" rowspan="1">Mean</td><td colspan="1" rowspan="1">Within-Run</td><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">Mean</td><td colspan="1" rowspan="1">Within-Run</td><td colspan="1" rowspan="1">Total</td></tr><tr><td colspan="1" rowspan="2">In-House</td><td colspan="1" rowspan="2">1</td><td colspan="1" rowspan="2">63.5</td><td colspan="1" rowspan="1">1.0 SD</td><td colspan="1" rowspan="1">1.2 SD</td><td colspan="1" rowspan="2">62.5</td><td colspan="1" rowspan="1">1.2 SD</td><td colspan="1" rowspan="1">1.3 SD</td></tr><tr><td colspan="1" rowspan="1">1.6%</td><td colspan="1" rowspan="1">1.9%</td><td colspan="1" rowspan="1">1.9%</td><td colspan="1" rowspan="1">2.1%</td></tr><tr><td colspan="1" rowspan="2">POL 1</td><td colspan="1" rowspan="2">1</td><td colspan="1" rowspan="2">62.7</td><td colspan="1" rowspan="1">0.6 SD</td><td colspan="1" rowspan="1">1.1 SD</td><td colspan="1" rowspan="2">64.3</td><td colspan="1" rowspan="1">1.1 SD</td><td colspan="1" rowspan="1">1.5 SD</td></tr><tr><td colspan="1" rowspan="1">1.0%</td><td colspan="1" rowspan="1">1.7%</td><td colspan="1" rowspan="1">1.7%</td><td colspan="1" rowspan="1">2.3%</td></tr><tr><td colspan="1" rowspan="2">POL 2</td><td colspan="1" rowspan="2">1</td><td colspan="1" rowspan="2">62.5</td><td colspan="1" rowspan="1">0.8 SD</td><td colspan="1" rowspan="1">1.3 SD</td><td colspan="1" rowspan="2">65.3</td><td colspan="1" rowspan="1">0.6 SD</td><td colspan="1" rowspan="1">0.9 SD</td></tr><tr><td colspan="1" rowspan="1">1.3%</td><td colspan="1" rowspan="1">2.1%</td><td colspan="1" rowspan="1">0.9%</td><td colspan="1" rowspan="1">1.3%</td></tr><tr><td colspan="1" rowspan="2">POL 3</td><td colspan="1" rowspan="2">1</td><td colspan="1" rowspan="2">63.2</td><td colspan="1" rowspan="1">0.8 SD</td><td colspan="1" rowspan="1">1.1 SD</td><td colspan="1" rowspan="2">64.7</td><td colspan="1" rowspan="1">0.5 SD</td><td colspan="1" rowspan="1">1.0 SD</td></tr><tr><td colspan="1" rowspan="1">1.3%</td><td colspan="1" rowspan="1">1.8%</td><td colspan="1" rowspan="1">0.8%</td><td colspan="1" rowspan="1">1.5%</td></tr><tr><td colspan="1" rowspan="1">:</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="2">In-House</td><td colspan="1" rowspan="2">2</td><td colspan="1" rowspan="2">305.7</td><td colspan="1" rowspan="1">1.3 SD</td><td colspan="1" rowspan="1">2.4 SD</td><td colspan="1" rowspan="2">300.0</td><td colspan="1" rowspan="1">2.4 SD</td><td colspan="1" rowspan="1">4.0 SD</td></tr><tr><td colspan="1" rowspan="1">0.4%</td><td colspan="1" rowspan="1">0.8%</td><td colspan="1" rowspan="1">0.8%</td><td colspan="1" rowspan="1">1.3%</td></tr><tr><td colspan="1" rowspan="2">POL 1</td><td colspan="1" rowspan="2">2</td><td colspan="1" rowspan="2">292.8</td><td colspan="1" rowspan="1">3.7 SD</td><td colspan="1" rowspan="1">4.7 SD</td><td colspan="1" rowspan="2">292.1</td><td colspan="1" rowspan="1">4.7 SD</td><td colspan="1" rowspan="1">6.6 SD</td></tr><tr><td colspan="1" rowspan="1">1.3%</td><td colspan="1" rowspan="1">1.6%</td><td colspan="1" rowspan="1">1.6%</td><td colspan="1" rowspan="1">2.3%</td></tr><tr><td colspan="1" rowspan="2">POL 2</td><td colspan="1" rowspan="2">2</td><td colspan="1" rowspan="2">298.4</td><td colspan="1" rowspan="1">2.6 SD</td><td colspan="1" rowspan="1">4.9 SD</td><td colspan="1" rowspan="2">296.6</td><td colspan="1" rowspan="1">4.6 SD</td><td colspan="1" rowspan="1">8.1 SD</td></tr><tr><td colspan="1" rowspan="1">0.9%</td><td colspan="1" rowspan="1">1.6%</td><td colspan="1" rowspan="1">1.6%</td><td colspan="1" rowspan="1">2.7%</td></tr><tr><td colspan="1" rowspan="2">POL 3</td><td colspan="1" rowspan="2">2</td><td colspan="1" rowspan="2">289.4</td><td colspan="1" rowspan="1">2.0 SD</td><td colspan="1" rowspan="1">4.5 SD</td><td colspan="1" rowspan="2">294.2</td><td colspan="1" rowspan="1">2.1 SD</td><td colspan="1" rowspan="1">4.3 SD</td></tr><tr><td colspan="1" rowspan="1">0.7%</td><td colspan="1" rowspan="1">1.6%</td><td colspan="1" rowspan="1">0.7%</td><td colspan="1" rowspan="1">1.5%</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">.</td><td colspan="1" rowspan="1">.</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="2">In-House</td><td colspan="1" rowspan="2">3</td><td colspan="1" rowspan="2">541.1</td><td colspan="1" rowspan="1">5.0 SD</td><td colspan="1" rowspan="1">7.3 SD</td><td colspan="1" rowspan="2">529.8</td><td colspan="1" rowspan="1">5.2 SD</td><td colspan="1" rowspan="1">12.6 SD</td></tr><tr><td colspan="1" rowspan="1">0.9%</td><td colspan="1" rowspan="1">1.3%</td><td colspan="1" rowspan="1">1.0%</td><td colspan="1" rowspan="1">2.4%</td></tr><tr><td colspan="1" rowspan="2">POL 1</td><td colspan="1" rowspan="2">3</td><td colspan="1" rowspan="2">508.4</td><td colspan="1" rowspan="1">9.2 SD</td><td colspan="1" rowspan="1">13.1 SD</td><td colspan="1" rowspan="2">500.7</td><td colspan="1" rowspan="1">11.5 SD</td><td colspan="1" rowspan="1">13.8 SD</td></tr><tr><td colspan="1" rowspan="1">1.8%</td><td colspan="1" rowspan="1">2.6%</td><td colspan="1" rowspan="1">2.3%</td><td colspan="1" rowspan="1">2.8%</td></tr><tr><td colspan="1" rowspan="2">POL 2</td><td colspan="1" rowspan="2">3</td><td colspan="1" rowspan="2">522.3</td><td colspan="1" rowspan="1">8.7 SD</td><td colspan="1" rowspan="1">11.8 SD</td><td colspan="1" rowspan="2">513.6</td><td colspan="1" rowspan="1">12.4 SD</td><td colspan="1" rowspan="1">13.9 SD</td></tr><tr><td colspan="1" rowspan="1">1.7%</td><td colspan="1" rowspan="1">2.3%</td><td colspan="1" rowspan="1">2.4%</td><td colspan="1" rowspan="1">2.7%</td></tr><tr><td colspan="1" rowspan="2">POL 3</td><td colspan="1" rowspan="2">3</td><td colspan="1" rowspan="2">506.8</td><td colspan="1" rowspan="1">3.1 SD</td><td colspan="1" rowspan="1">8.4 SD</td><td colspan="1" rowspan="2">508.8</td><td colspan="1" rowspan="1">4.2 SD</td><td colspan="1" rowspan="1">6.5 SD</td></tr><tr><td colspan="1" rowspan="1">0.6%</td><td colspan="1" rowspan="1">1.7%</td><td colspan="1" rowspan="1">0.8%</td><td colspan="1" rowspan="1">1.3%</td></tr><tr><td colspan="8" rowspan="1">Y° ..,</td></tr><tr><td colspan="2" rowspan="1">" Sodium</td><td colspan="3" rowspan="1">ACESD (mmol/L) or %CV</td><td colspan="3" rowspan="1">ACE AleraSD (mmol/L) or %CV</td></tr><tr><td colspan="1" rowspan="1">Lab</td><td colspan="1" rowspan="1">Sample</td><td colspan="1" rowspan="1">Mean</td><td colspan="1" rowspan="1">Within-Run</td><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">:Mean</td><td colspan="1" rowspan="1">Within-Run</td><td colspan="1" rowspan="1">Total</td></tr><tr><td colspan="1" rowspan="2">In-House</td><td colspan="1" rowspan="2">1</td><td colspan="1" rowspan="2">108.1</td><td colspan="1" rowspan="1">0.72 SD</td><td colspan="1" rowspan="1">0.95 SD</td><td colspan="1" rowspan="2">1107.5</td><td colspan="1" rowspan="1">0.80 SD</td><td colspan="1" rowspan="1">1.50 SD</td></tr><tr><td colspan="1" rowspan="1">0.7%</td><td colspan="1" rowspan="1">0.9%</td><td colspan="1" rowspan="1">0.7%</td><td colspan="1" rowspan="1">1.4%</td></tr><tr><td colspan="1" rowspan="2">POL 1</td><td colspan="1" rowspan="2">1</td><td colspan="1" rowspan="2">108.7</td><td colspan="1" rowspan="1">1.20 SD</td><td colspan="1" rowspan="1">1.80 SD</td><td colspan="1" rowspan="2">108.4</td><td colspan="1" rowspan="1">0.93 SD</td><td colspan="1" rowspan="1">1.44 SD</td></tr><tr><td colspan="1" rowspan="1">1.1%</td><td colspan="1" rowspan="1">1.6%</td><td colspan="1" rowspan="1">0.9%</td><td colspan="1" rowspan="1">1.3%</td></tr><tr><td colspan="1" rowspan="2">POL 2</td><td colspan="1" rowspan="2">1</td><td colspan="1" rowspan="2">108</td><td colspan="1" rowspan="1">0.90 SD</td><td colspan="1" rowspan="1">1.70 SD</td><td colspan="1" rowspan="2">1108.1</td><td colspan="1" rowspan="1">0.94 SD</td><td colspan="1" rowspan="1">1.16 SD</td></tr><tr><td colspan="1" rowspan="1">0.9%</td><td colspan="1" rowspan="1">1.6%</td><td colspan="1" rowspan="1">0.9%</td><td colspan="1" rowspan="1">1.1%</td></tr><tr><td colspan="1" rowspan="2">POL 3</td><td colspan="1" rowspan="2">1</td><td colspan="1" rowspan="2">109.6</td><td colspan="1" rowspan="1">0.60 SD</td><td colspan="1" rowspan="1">0.90 SD</td><td colspan="1" rowspan="2">107.0</td><td colspan="1" rowspan="1">0.56 SD</td><td colspan="1" rowspan="1">0.98 SD</td></tr><tr><td colspan="1" rowspan="1">0.6%</td><td colspan="1" rowspan="1">0.8%</td><td colspan="1" rowspan="1">0.5%</td><td colspan="1" rowspan="1">0.9%</td></tr><tr><td colspan="1" rowspan="1">:". y";</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">: *my</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">    .</td></tr><tr><td colspan="1" rowspan="2">In-House</td><td colspan="1" rowspan="2">2</td><td colspan="1" rowspan="2">149.2</td><td colspan="1" rowspan="1">0.53 SD</td><td colspan="1" rowspan="1">0.65 SD</td><td colspan="1" rowspan="2">149.2</td><td colspan="1" rowspan="1">0.60 SD</td><td colspan="1" rowspan="1">0.70 SD</td></tr><tr><td colspan="1" rowspan="1">0.4%</td><td colspan="1" rowspan="1">0.4%</td><td colspan="1" rowspan="1">0.4%</td><td colspan="1" rowspan="1">0.5%</td></tr><tr><td colspan="1" rowspan="2">POL 1</td><td colspan="1" rowspan="2">2</td><td colspan="1" rowspan="2">146.9</td><td colspan="1" rowspan="1">1.20 SD</td><td colspan="1" rowspan="1">1.20 SD</td><td colspan="1" rowspan="2">148.7</td><td colspan="1" rowspan="1">1.41 SD</td><td colspan="1" rowspan="1">1.72 SD</td></tr><tr><td colspan="1" rowspan="1">0.8%</td><td colspan="1" rowspan="1">0.8%</td><td colspan="1" rowspan="1">0.9%</td><td colspan="1" rowspan="1">1.2%</td></tr><tr><td colspan="1" rowspan="2">POL 2</td><td colspan="1" rowspan="2">2</td><td colspan="1" rowspan="2">149.4</td><td colspan="1" rowspan="1">1.00 SD</td><td colspan="1" rowspan="1">1.00 SD</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">0.56 SD</td><td colspan="1" rowspan="1">0.80 SD</td></tr><tr><td colspan="1" rowspan="1">0.7%</td><td colspan="1" rowspan="1">0.7%</td><td colspan="1" rowspan="1">146.1</td><td colspan="1" rowspan="1">0.4%</td><td colspan="1" rowspan="1">0.5%</td></tr><tr><td colspan="1" rowspan="2">POL 3</td><td colspan="1" rowspan="2">2</td><td colspan="1" rowspan="2">147.6</td><td colspan="1" rowspan="1">1.00 SD</td><td colspan="1" rowspan="1">1.30 SD</td><td colspan="1" rowspan="2">147.6</td><td colspan="1" rowspan="1">0.95 SD</td><td colspan="1" rowspan="1">0.95 SD</td></tr><tr><td colspan="1" rowspan="1">0.7%</td><td colspan="1" rowspan="1">0.9%</td><td colspan="1" rowspan="1">0.6%</td><td colspan="1" rowspan="1">0.6%</td></tr><tr><td colspan="1" rowspan="1">:</td><td colspan="1" rowspan="1">: :-</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">EM</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">:</td><td colspan="1" rowspan="1">:</td><td colspan="1" rowspan="1">'</td></tr><tr><td colspan="1" rowspan="2">In-House</td><td colspan="1" rowspan="2">3</td><td colspan="1" rowspan="2">196.4</td><td colspan="1" rowspan="1">2.07 SD</td><td colspan="1" rowspan="1">2.58 SD</td><td colspan="1" rowspan="2">197.1</td><td colspan="1" rowspan="1">1.80 SD</td><td colspan="1" rowspan="1">2.10 SD</td></tr><tr><td colspan="1" rowspan="1">1.1%</td><td colspan="1" rowspan="1">1.3%</td><td colspan="1" rowspan="1">0.9%</td><td colspan="1" rowspan="1">1.1%</td></tr><tr><td colspan="1" rowspan="2">POL 1</td><td colspan="1" rowspan="2">.3</td><td colspan="1" rowspan="2">190.2</td><td colspan="1" rowspan="1">1.70 SD</td><td colspan="1" rowspan="1">1.90 SD</td><td colspan="1" rowspan="2">193.7</td><td colspan="1" rowspan="1">1.33 SD</td><td colspan="1" rowspan="1">2.74 SD</td></tr><tr><td colspan="1" rowspan="1">0.9%</td><td colspan="1" rowspan="1">1.0%</td><td colspan="1" rowspan="1">0.7%</td><td colspan="1" rowspan="1">1.4%</td></tr><tr><td colspan="1" rowspan="2">POL 2</td><td colspan="1" rowspan="2">3</td><td colspan="1" rowspan="2">197.4</td><td colspan="1" rowspan="1">1.20 SD</td><td colspan="1" rowspan="1">2.60 SD</td><td colspan="1" rowspan="2">189.4</td><td colspan="1" rowspan="1">0.80 SD</td><td colspan="1" rowspan="1">1.31 SD</td></tr><tr><td colspan="1" rowspan="1">0.6%</td><td colspan="1" rowspan="1">1.3%</td><td colspan="1" rowspan="1">0.4%</td><td colspan="1" rowspan="1">0.7%</td></tr><tr><td colspan="1" rowspan="2">POL 3</td><td colspan="1" rowspan="2">3</td><td colspan="1" rowspan="2">190.6</td><td colspan="1" rowspan="1">0.80 SD</td><td colspan="1" rowspan="1">1.70 SD</td><td colspan="1" rowspan="2">192.7</td><td colspan="1" rowspan="1">1.09 SD</td><td colspan="1" rowspan="1">1.09 SD</td></tr><tr><td colspan="1" rowspan="1">0.40%</td><td colspan="1" rowspan="1">0.9%</td><td colspan="1" rowspan="1">0.6%</td><td colspan="1" rowspan="1">0.6%</td></tr></table>

<table><tr><td rowspan=1 colspan=2>$    Potassium</td><td rowspan=1 colspan=3>ACESD (mmol/L) or %CV</td><td rowspan=1 colspan=3>ACE AleraSD (mmol/L) or %CV</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Lab</td><td rowspan=1 colspan=1>Sample</td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>Within-Run</td><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>Within-Run</td><td rowspan=1 colspan=1>Total</td></tr><tr><td rowspan=2 colspan=1>In-House</td><td rowspan=2 colspan=1>1</td><td rowspan=2 colspan=1>3.72</td><td rowspan=1 colspan=1>0.05 SD</td><td rowspan=1 colspan=1>0.05 SD</td><td rowspan=2 colspan=1>3.70</td><td rowspan=1 colspan=1>0.06 SD</td><td rowspan=1 colspan=1>0.06 SD</td></tr><tr><td rowspan=1 colspan=1>1.2%</td><td rowspan=1 colspan=1>1.3%</td><td rowspan=1 colspan=1>1.6%</td><td rowspan=1 colspan=1>1.7%</td></tr><tr><td rowspan=2 colspan=1>POL 1.</td><td rowspan=2 colspan=1>1</td><td rowspan=2 colspan=1>3.78</td><td rowspan=1 colspan=1>0.09 SD</td><td rowspan=1 colspan=1>0.09 SD</td><td rowspan=2 colspan=1>3.73</td><td rowspan=1 colspan=1>0.07 SD</td><td rowspan=1 colspan=1>0.08 SD</td></tr><tr><td rowspan=1 colspan=1>2.4%</td><td rowspan=1 colspan=1>2.5%</td><td rowspan=1 colspan=1>1.8%</td><td rowspan=1 colspan=1>2.2%</td></tr><tr><td rowspan=2 colspan=1>POL 2</td><td rowspan=2 colspan=1>1</td><td rowspan=2 colspan=1>3.71</td><td rowspan=1 colspan=1>0.02 SD</td><td rowspan=1 colspan=1>0.02 SD</td><td rowspan=2 colspan=1>3.77</td><td rowspan=1 colspan=1>0.06 SD</td><td rowspan=1 colspan=1>0.07 SD</td></tr><tr><td rowspan=1 colspan=1>0.6%</td><td rowspan=1 colspan=1>0.6%</td><td rowspan=1 colspan=1>1.7%</td><td rowspan=1 colspan=1>1.8%</td></tr><tr><td rowspan=2 colspan=1>POL 3</td><td rowspan=2 colspan=1>1</td><td rowspan=2 colspan=1>3.76</td><td rowspan=1 colspan=1>0.07 SD</td><td rowspan=1 colspan=1>0.07 SD</td><td rowspan=2 colspan=1>3.73</td><td rowspan=1 colspan=1>0.05 SD</td><td rowspan=1 colspan=1>0.06 SD</td></tr><tr><td rowspan=1 colspan=1>1.8%</td><td rowspan=1 colspan=1>1.8%</td><td rowspan=1 colspan=1>1.3%</td><td rowspan=1 colspan=1>1.6%</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>:</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=2 colspan=1>In-House</td><td rowspan=2 colspan=1>2</td><td rowspan=2 colspan=1>6.52</td><td rowspan=1 colspan=1>0.13 SD</td><td rowspan=1 colspan=1>0.13 SD</td><td rowspan=2 colspan=1>6.56</td><td rowspan=1 colspan=1>0.13 SD</td><td rowspan=1 colspan=1>0.14 SD</td></tr><tr><td rowspan=1 colspan=1>2.0%</td><td rowspan=1 colspan=1>2.0%</td><td rowspan=1 colspan=1>2.0%</td><td rowspan=1 colspan=1>2.1%</td></tr><tr><td rowspan=2 colspan=1>POL 1</td><td rowspan=2 colspan=1>2</td><td rowspan=2 colspan=1>6.68</td><td rowspan=1 colspan=1>0.08 SD</td><td rowspan=1 colspan=1>0.09 SD</td><td rowspan=2 colspan=1>6.89</td><td rowspan=1 colspan=1>0.13 SD</td><td rowspan=1 colspan=1>0.16 SD</td></tr><tr><td rowspan=1 colspan=1>1.2%</td><td rowspan=1 colspan=1>1.4%</td><td rowspan=1 colspan=1>1.8%</td><td rowspan=1 colspan=1>2.4%</td></tr><tr><td rowspan=2 colspan=1>•POL 2</td><td rowspan=2 colspan=1>2</td><td rowspan=2 colspan=1>6.49</td><td rowspan=1 colspan=1>0.05 SD</td><td rowspan=1 colspan=1>0.05 SD</td><td rowspan=2 colspan=1>6.70</td><td rowspan=1 colspan=1>0.08 SD</td><td rowspan=1 colspan=1>0.09 SD</td></tr><tr><td rowspan=1 colspan=1>0.8%</td><td rowspan=1 colspan=1>0.8%</td><td rowspan=1 colspan=1>1.2%</td><td rowspan=1 colspan=1>1.3%</td></tr><tr><td rowspan=2 colspan=1>POL 3</td><td rowspan=2 colspan=1>2</td><td rowspan=2 colspan=1>6.74</td><td rowspan=1 colspan=1>0.07 SD</td><td rowspan=1 colspan=1>0.07 SD</td><td rowspan=2 colspan=1>6.67</td><td rowspan=1 colspan=1>0.05 SD</td><td rowspan=1 colspan=1>0.10 SD</td></tr><tr><td rowspan=1 colspan=1>1.0%</td><td rowspan=1 colspan=1>1.0%</td><td rowspan=1 colspan=1>0.8%</td><td rowspan=1 colspan=1>1.4%</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>$frac  $</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>&#x27;</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=2 colspan=1>In-House</td><td rowspan=2 colspan=1>3</td><td rowspan=2 colspan=1>9.56</td><td rowspan=1 colspan=1>0.11 SD</td><td rowspan=1 colspan=1>0.17 SD</td><td rowspan=2 colspan=1>9.73</td><td rowspan=1 colspan=1>0.09 SD</td><td rowspan=1 colspan=1>0.19 SD</td></tr><tr><td rowspan=1 colspan=1>1.1%</td><td rowspan=1 colspan=1>1.8%</td><td rowspan=1 colspan=1>0.9%</td><td rowspan=1 colspan=1>2.0%</td></tr><tr><td rowspan=2 colspan=1>POL 1</td><td rowspan=2 colspan=1>3</td><td rowspan=2 colspan=1>9.90</td><td rowspan=1 colspan=1>0.21 SD</td><td rowspan=1 colspan=1>0.22 SD</td><td rowspan=2 colspan=1>10.36</td><td rowspan=1 colspan=1>0.08 SD</td><td rowspan=1 colspan=1>0.19 SD</td></tr><tr><td rowspan=1 colspan=1>2.2%</td><td rowspan=1 colspan=1>2.2%</td><td rowspan=1 colspan=1>0.8%</td><td rowspan=1 colspan=1>1.8%</td></tr><tr><td rowspan=2 colspan=1>POL 2</td><td rowspan=2 colspan=1>3</td><td rowspan=2 colspan=1>9.56</td><td rowspan=1 colspan=1>0.07 SD</td><td rowspan=1 colspan=1>0.11 SD</td><td rowspan=2 colspan=1>10.04</td><td rowspan=1 colspan=1>0.04 SD</td><td rowspan=1 colspan=1>0.19 SD</td></tr><tr><td rowspan=1 colspan=1>0.8%</td><td rowspan=1 colspan=1>1.2%</td><td rowspan=1 colspan=1>0.4%</td><td rowspan=1 colspan=1>1.9%</td></tr><tr><td rowspan=2 colspan=1>POL 3</td><td rowspan=2 colspan=1>3</td><td rowspan=2 colspan=1>10.08</td><td rowspan=1 colspan=1>0.06 SD</td><td rowspan=1 colspan=1>0.11 SD</td><td rowspan=2 colspan=1>9.92</td><td rowspan=1 colspan=1>0.15 SD</td><td rowspan=1 colspan=1>0.22 SD</td></tr><tr><td rowspan=1 colspan=1>0.6%</td><td rowspan=1 colspan=1>1.1%</td><td rowspan=1 colspan=1>1.5%</td><td rowspan=1 colspan=1>2.2%</td></tr></table>

<table><tr><td rowspan=1 colspan=2>Chloride</td><td rowspan=1 colspan=3>ACESD (mmol/L) or %CV</td><td rowspan=1 colspan=3>ACE Alera        ×SD (mmol/L) or %CV</td></tr><tr><td rowspan=1 colspan=1>Lab</td><td rowspan=1 colspan=1>Sample</td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>Within-Run</td><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>Within-Run</td><td rowspan=1 colspan=1>Total</td></tr><tr><td rowspan=2 colspan=1>In-House</td><td rowspan=2 colspan=1>1</td><td rowspan=2 colspan=1>77.6</td><td rowspan=1 colspan=1>0.37 SD</td><td rowspan=1 colspan=1>0.69 SD</td><td rowspan=2 colspan=1>77.3</td><td rowspan=1 colspan=1>0.50 SD</td><td rowspan=1 colspan=1>1.20 SD</td></tr><tr><td rowspan=1 colspan=1>0.5%</td><td rowspan=1 colspan=1>0.9%</td><td rowspan=1 colspan=1>0.6%</td><td rowspan=1 colspan=1>1.6%</td></tr><tr><td rowspan=2 colspan=1>POL 1</td><td rowspan=2 colspan=1>1</td><td rowspan=2 colspan=1>79.2</td><td rowspan=1 colspan=1>1.40 SD</td><td rowspan=1 colspan=1>1.70 SD</td><td rowspan=2 colspan=1>78.1</td><td rowspan=1 colspan=1>0.76 SD</td><td rowspan=1 colspan=1>1.30 SD</td></tr><tr><td rowspan=1 colspan=1>1.8%</td><td rowspan=1 colspan=1>2.1%</td><td rowspan=1 colspan=1>1.0%</td><td rowspan=1 colspan=1>1.7%</td></tr><tr><td rowspan=2 colspan=1>POL 2</td><td rowspan=2 colspan=1>1</td><td rowspan=2 colspan=1>78.1</td><td rowspan=1 colspan=1>0.60 SD</td><td rowspan=1 colspan=1>0.70 SD</td><td rowspan=2 colspan=1>78.4</td><td rowspan=1 colspan=1>0.89 SD</td><td rowspan=1 colspan=1>1.24 SD</td></tr><tr><td rowspan=1 colspan=1>0.8%</td><td rowspan=1 colspan=1>0.9%</td><td rowspan=1 colspan=1>1.1%</td><td rowspan=1 colspan=1>1.6%</td></tr><tr><td rowspan=2 colspan=1>POL 3</td><td rowspan=2 colspan=1>1</td><td rowspan=2 colspan=1>79.1</td><td rowspan=1 colspan=1>0.90 SD</td><td rowspan=1 colspan=1>1.20 SD</td><td rowspan=2 colspan=1>78.1</td><td rowspan=1 colspan=1>0.48 SD</td><td rowspan=1 colspan=1>0.54 SD</td></tr><tr><td rowspan=1 colspan=1>1.1%</td><td rowspan=1 colspan=1>1.5%</td><td rowspan=1 colspan=1>0.6%</td><td rowspan=1 colspan=1>0.7%</td></tr><tr><td rowspan=1 colspan=1>::2</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>.</td><td rowspan=1 colspan=1>&quot; ::</td><td rowspan=1 colspan=1>K&lt;  *</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=2 colspan=1>In-House</td><td rowspan=2 colspan=1>2</td><td rowspan=2 colspan=1>108.2</td><td rowspan=1 colspan=1>1.33 SD</td><td rowspan=1 colspan=1>1.40 SD</td><td rowspan=2 colspan=1>108.3</td><td rowspan=1 colspan=1>1.20 SD</td><td rowspan=1 colspan=1>1.30 SD</td></tr><tr><td rowspan=1 colspan=1>1.2%</td><td rowspan=1 colspan=1>1.3%</td><td rowspan=1 colspan=1>1.1%</td><td rowspan=1 colspan=1>1.2%</td></tr><tr><td rowspan=2 colspan=1>POL 1</td><td rowspan=2 colspan=1>2</td><td rowspan=2 colspan=1>108.1</td><td rowspan=1 colspan=1>0.70 SD</td><td rowspan=1 colspan=1>0.80 SD</td><td rowspan=2 colspan=1>109.0</td><td rowspan=1 colspan=1> 1.42 SD</td><td rowspan=1 colspan=1>1.42 SD</td></tr><tr><td rowspan=1 colspan=1>0.7%</td><td rowspan=1 colspan=1>0.7%</td><td rowspan=1 colspan=1>1.3%</td><td rowspan=1 colspan=1>1.3%</td></tr><tr><td rowspan=2 colspan=1>POL 2</td><td rowspan=2 colspan=1>2</td><td rowspan=2 colspan=1>107.3</td><td rowspan=1 colspan=1>0.40 SD</td><td rowspan=1 colspan=1>0.50 SD</td><td rowspan=2 colspan=1>107.7</td><td rowspan=1 colspan=1>0.69 SD</td><td rowspan=1 colspan=1>0.85 SD</td></tr><tr><td rowspan=1 colspan=1>0.4%</td><td rowspan=1 colspan=1>0.5%</td><td rowspan=1 colspan=1>0.6%</td><td rowspan=1 colspan=1>0.8%</td></tr><tr><td rowspan=2 colspan=1>POL 3</td><td rowspan=2 colspan=1>2</td><td rowspan=2 colspan=1>108.2</td><td rowspan=1 colspan=1>0.80 SD</td><td rowspan=1 colspan=1>1.10 SD</td><td rowspan=2 colspan=1>108.2</td><td rowspan=1 colspan=1>0.60 SD</td><td rowspan=1 colspan=1>0.67 SD</td></tr><tr><td rowspan=1 colspan=1>0.7%</td><td rowspan=1 colspan=1>1.0%</td><td rowspan=1 colspan=1>0.6%</td><td rowspan=1 colspan=1>0.6%</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>.:</td></tr><tr><td rowspan=2 colspan=1>In-House</td><td rowspan=2 colspan=1>3</td><td rowspan=2 colspan=1>142.0</td><td rowspan=1 colspan=1>1.59 SD</td><td rowspan=1 colspan=1>1.81 SD</td><td rowspan=2 colspan=1>143.4</td><td rowspan=1 colspan=1>1.70 SD</td><td rowspan=1 colspan=1>1.80 SD</td></tr><tr><td rowspan=1 colspan=1>1.1%</td><td rowspan=1 colspan=1>1.3%</td><td rowspan=1 colspan=1>1.2%</td><td rowspan=1 colspan=1>1.3%</td></tr><tr><td rowspan=2 colspan=1>POL 1</td><td rowspan=2 colspan=1>3</td><td rowspan=2 colspan=1>140.5</td><td rowspan=1 colspan=1>1.50 SD</td><td rowspan=1 colspan=1>1.60 SD</td><td rowspan=2 colspan=1>142.8</td><td rowspan=1 colspan=1>1.11 SD</td><td rowspan=1 colspan=1>2.04 SD</td></tr><tr><td rowspan=1 colspan=1>1.1%</td><td rowspan=1 colspan=1>1.2%</td><td rowspan=1 colspan=1>0.8%</td><td rowspan=1 colspan=1>1.4%</td></tr><tr><td rowspan=2 colspan=1>POL 2</td><td rowspan=2 colspan=1>3</td><td rowspan=2 colspan=1>139.8</td><td rowspan=1 colspan=1>0.70 SD</td><td rowspan=1 colspan=1>1.10 SD</td><td rowspan=2 colspan=1>141.2</td><td rowspan=1 colspan=1>0.73 SD</td><td rowspan=1 colspan=1>1.69 SD</td></tr><tr><td rowspan=1 colspan=1>0.5%</td><td rowspan=1 colspan=1>0.8%</td><td rowspan=1 colspan=1>0.5%</td><td rowspan=1 colspan=1>1.2%</td></tr><tr><td rowspan=2 colspan=1>POL 3</td><td rowspan=2 colspan=1>3</td><td rowspan=2 colspan=1>140.1</td><td rowspan=1 colspan=1>0.60 SD</td><td rowspan=1 colspan=1>1.10 SD</td><td rowspan=2 colspan=1>142.2</td><td rowspan=1 colspan=1>0.61 SD</td><td rowspan=1 colspan=1>0.75 SD</td></tr><tr><td rowspan=1 colspan=1>0.5%</td><td rowspan=1 colspan=1>0.8%</td><td rowspan=1 colspan=1>0.4%</td><td rowspan=1 colspan=1>0.5%</td></tr></table>

<table><tr><td>, </td></tr><tr><td></td></tr><tr><td></td></tr><tr><td></td></tr></table>

# Interferences

<table><tr><td rowspan=1 colspan=1>ACE Alera</td><td rowspan=1 colspan=1>Icterus</td><td rowspan=1 colspan=1>Hemolysis</td><td rowspan=1 colspan=1>Lipemia(Intralipid)(Turbidity)</td><td rowspan=1 colspan=1>Lipemia(Triglycerides)(Avian)</td><td rowspan=1 colspan=1>AscorbicAcid</td></tr><tr><td rowspan=1 colspan=1>GLU</td><td rowspan=1 colspan=1>No significantinterference ator below26 mg/dL</td><td rowspan=1 colspan=1>No significantinterference ator below1000 mg/dL</td><td rowspan=1 colspan=1>Nosignificantinterferenceat or below104 mg/dL</td><td rowspan=1 colspan=1>No significantinterference ator below525 mg/dL</td><td rowspan=1 colspan=1>Nosignificantinterferenceat or below6 mg/dL</td></tr><tr><td rowspan=1 colspan=1>NA</td><td rowspan=1 colspan=1>No significantinterference ator below50 mg/dL</td><td rowspan=1 colspan=1>No significantinterference ator below1000 mg/dL</td><td rowspan=1 colspan=1>Nosignificantinterferenceat or below125 mg/dL</td><td rowspan=3 colspan=1>No significantinterference ator below656 mg/dLNo significantinterference ator below420 mg/dLNo significantinterference ator below. 420 mg/dL1</td><td rowspan=3 colspan=1>Nosignificantinterferenceat or below6 mg/dLNosignificantinterferenceat or below6 mg/dLNosignificantinterferenceat or below6 mg/dL</td></tr><tr><td rowspan=1 colspan=1>K</td><td rowspan=1 colspan=1>No significantinterference ator below50 mg/dL</td><td rowspan=1 colspan=1>No significantinterference ator below125 mg/dL</td><td rowspan=1 colspan=1>Nosignificantinterferenceat or below125 mg/dL</td></tr><tr><td rowspan=1 colspan=1>CL</td><td rowspan=1 colspan=1>No significantinterference ator below50 mg/dL</td><td rowspan=1 colspan=1>No significantinterference ator below1000 mg/dL</td><td rowspan=1 colspan=1>Nosignificantinterferenceat or below125 mg/dL</td></tr></table>

<table><tr><td rowspan=1 colspan=5>Method Comparison Data-Ace vs. Alera POL&#x27;s</td></tr><tr><td rowspan=1 colspan=2>Glucose              mg/dL</td><td rowspan=1 colspan=3>*TACE Alera</td></tr><tr><td rowspan=9 colspan=1>MethodComparison:ACE systemIn-House vs.ACE Alerasystem POL(2012 Data)</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>POL 1</td><td rowspan=1 colspan=1>POL 2</td><td rowspan=1 colspan=1>POL 3</td></tr><tr><td rowspan=1 colspan=1>n</td><td rowspan=1 colspan=1>46</td><td rowspan=1 colspan=1>46</td><td rowspan=1 colspan=1>46</td></tr><tr><td rowspan=1 colspan=1>Range (mg/dL)</td><td rowspan=1 colspan=1>22-625</td><td rowspan=1 colspan=1>22-625</td><td rowspan=1 colspan=1>22-625</td></tr><tr><td rowspan=1 colspan=1>Slope</td><td rowspan=1 colspan=1>1.015</td><td rowspan=1 colspan=1>1.005</td><td rowspan=1 colspan=1>0.988</td></tr><tr><td rowspan=1 colspan=1>Intercept</td><td rowspan=1 colspan=1>0.1</td><td rowspan=1 colspan=1>3.1</td><td rowspan=1 colspan=1>3.2</td></tr><tr><td rowspan=1 colspan=1>CorrelationCoefficient</td><td rowspan=1 colspan=1>0.9993</td><td rowspan=1 colspan=1>0.9995</td><td rowspan=1 colspan=1>0.9993</td></tr><tr><td rowspan=1 colspan=1>Std. Error</td><td rowspan=1 colspan=1>4.8</td><td rowspan=1 colspan=1>3.9</td><td rowspan=1 colspan=1>4.4</td></tr><tr><td rowspan=1 colspan=1>CI Slope</td><td rowspan=1 colspan=1>1.003 to 1.027</td><td rowspan=1 colspan=1>0.995 to 1.015</td><td rowspan=1 colspan=1>0.978 to 0.999</td></tr><tr><td rowspan=1 colspan=1>CI Intercept</td><td rowspan=1 colspan=1>-2.2 to 2.3</td><td rowspan=1 colspan=1>1.3 to 4.9</td><td rowspan=1 colspan=1>1.1 to 5.2</td></tr></table>

<table><tr><td rowspan=1 colspan=2>Sodium             mmol/L</td><td rowspan=1 colspan=3>ACE Alera</td></tr><tr><td rowspan=9 colspan=1>MethodComparison:ACE systemIn-House vs.ACE Alerasystem POL(2012 Data)</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>POL 1</td><td rowspan=1 colspan=1>POL 2</td><td rowspan=1 colspan=1>POL 3</td></tr><tr><td rowspan=1 colspan=1>n</td><td rowspan=1 colspan=1>42</td><td rowspan=1 colspan=1>42</td><td rowspan=1 colspan=1>42</td></tr><tr><td rowspan=1 colspan=1>Range (mmol/L)</td><td rowspan=1 colspan=1>51-202</td><td rowspan=1 colspan=1>51-202</td><td rowspan=1 colspan=1>51-202</td></tr><tr><td rowspan=1 colspan=1>Slope</td><td rowspan=1 colspan=1>1.025</td><td rowspan=1 colspan=1>1.021</td><td rowspan=1 colspan=1>1.044</td></tr><tr><td rowspan=1 colspan=1>Intercept</td><td rowspan=1 colspan=1>-1.74</td><td rowspan=1 colspan=1>-2.92</td><td rowspan=1 colspan=1>-6.27</td></tr><tr><td rowspan=1 colspan=1>CorrelationCoefficient</td><td rowspan=1 colspan=1>0.9974</td><td rowspan=1 colspan=1>0.9958</td><td rowspan=1 colspan=1>0.9979</td></tr><tr><td rowspan=1 colspan=1>Std. Error</td><td rowspan=1 colspan=1>2.05</td><td rowspan=1 colspan=1>2.59</td><td rowspan=1 colspan=1>1.87</td></tr><tr><td rowspan=1 colspan=1>CI Slope</td><td rowspan=1 colspan=1>1.001 to 1.049</td><td rowspan=1 colspan=1>0.991 to 1.051</td><td rowspan=1 colspan=1>1.022 to 1.065</td></tr><tr><td rowspan=1 colspan=1>CI Intercept</td><td rowspan=1 colspan=1>-5.04 to 1.55</td><td rowspan=1 colspan=1>-7.08 to 1.24</td><td rowspan=1 colspan=1>-9.27 to -3.27</td></tr></table>

<table><tr><td rowspan=1 colspan=2>:.Potassium            mmol/L</td><td rowspan=1 colspan=3>ACE Alera</td></tr><tr><td rowspan=9 colspan=1>MethodComparison:ACE systemIn-House vs.ACE Alerasystem POL(2012 Data)</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>POL 1</td><td rowspan=1 colspan=1>POL 2</td><td rowspan=1 colspan=1>POL 3</td></tr><tr><td rowspan=1 colspan=1>n</td><td rowspan=1 colspan=1>43</td><td rowspan=1 colspan=1>43</td><td rowspan=1 colspan=1>43</td></tr><tr><td rowspan=1 colspan=1>Range (mmol/L)</td><td rowspan=1 colspan=1>1.8-13.7</td><td rowspan=1 colspan=1>1.8-13.7</td><td rowspan=1 colspan=1>1.8-13.7</td></tr><tr><td rowspan=1 colspan=1>Slope</td><td rowspan=1 colspan=1>1.032</td><td rowspan=1 colspan=1>1.008</td><td rowspan=1 colspan=1>0.984</td></tr><tr><td rowspan=1 colspan=1>Intercept</td><td rowspan=1 colspan=1>-0.108</td><td rowspan=1 colspan=1>-0.054</td><td rowspan=1 colspan=1>0.150</td></tr><tr><td rowspan=1 colspan=1>CorrelationCoefficient</td><td rowspan=1 colspan=1>0.9983</td><td rowspan=1 colspan=1>0.9971</td><td rowspan=1 colspan=1>0.9942</td></tr><tr><td rowspan=1 colspan=1>Std. Error</td><td rowspan=1 colspan=1>0.131</td><td rowspan=1 colspan=1>0.166</td><td rowspan=1 colspan=1>0.230</td></tr><tr><td rowspan=1 colspan=1>CI Slope</td><td rowspan=1 colspan=1>1.013 to 1.051</td><td rowspan=1 colspan=1>0.984 to 1.032</td><td rowspan=1 colspan=1>0.951 to 1.018</td></tr><tr><td rowspan=1 colspan=1>CI Intercept</td><td rowspan=1 colspan=1>-0.212 to -0.005</td><td rowspan=1 colspan=1>-0.185 to 0.077</td><td rowspan=1 colspan=1>-0.031 to 0.332</td></tr></table>

<table><tr><td rowspan=11 colspan=3>ChlorideMethodComparison:ACE systemIn-House vs.ACE Alerasystem POL(2012 Data)</td><td rowspan=1 colspan=2>Chloride            mmol/L</td><td rowspan=1 colspan=2>ACE Alera      · . $.</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>POL 1</td><td rowspan=1 colspan=1>POL 2</td><td rowspan=1 colspan=1>POL 3</td></tr><tr><td rowspan=1 colspan=1>n</td><td rowspan=1 colspan=1>41</td><td rowspan=1 colspan=1>41</td><td rowspan=1 colspan=1>41</td></tr><tr><td rowspan=1 colspan=1>Range (mmol/L)</td><td rowspan=1 colspan=1>59-187</td><td rowspan=1 colspan=1>59-187</td><td rowspan=1 colspan=1>59-187</td></tr><tr><td rowspan=1 colspan=1>Slope</td><td rowspan=1 colspan=1>1.004</td><td rowspan=1 colspan=1>1.000</td><td rowspan=1 colspan=1>1.006</td></tr><tr><td rowspan=1 colspan=1>Intercept</td><td rowspan=1 colspan=1>0.96</td><td rowspan=1 colspan=1>0.29</td><td rowspan=1 colspan=1>0.16</td></tr><tr><td rowspan=1 colspan=1>CorrelationCoefficient</td><td rowspan=1 colspan=1>0.9972</td><td rowspan=1 colspan=1>0.9956</td><td rowspan=1 colspan=1>0.9946</td></tr><tr><td rowspan=1 colspan=1>Std. Error</td><td rowspan=1 colspan=1>1.69</td><td rowspan=1 colspan=1>2.11</td><td rowspan=1 colspan=1>2.35</td></tr><tr><td rowspan=1 colspan=1>CI Slope</td><td rowspan=1 colspan=1>0.980 to 1.028</td><td rowspan=1 colspan=1>0.970 to 1.030</td><td rowspan=1 colspan=1>0.972 to 1.040</td></tr><tr><td rowspan=1 colspan=1>CI Intercept</td><td rowspan=1 colspan=1>-1.68 to 3.60</td><td rowspan=1 colspan=1>-3.02 to 3.60</td><td rowspan=1 colspan=1>-3.52 to 3.85</td></tr><tr><td rowspan=1 colspan=6></td></tr><tr><td rowspan=1 colspan=1>Conclusions:</td><td rowspan=1 colspan=6>Based on the foregoing data, the device is safe and effective. These data also indicatesubstantial equivalence for lithium heparin plasma sample collection tubes to the preddevice&#x27;s use of serum sample collection tubes.</td></tr></table>

# April 23, 2013

Alfa Wasserman Diagnostic Technologies, LLC C/O Hyman Katz, Ph.D.   
4 Henderson Drive   
WEST CALDWELL NJ 07006

Re: K123018 Trade/Device Name: ACE Alera Clinical Chemistry System ACE Glucose Reagent ACE Ion Selective Electrode (ISE) Module Regulation Number: 21 CFR 862.1345 Regulation Name: Glucose test system Regulatory Class: II Product Code: CFR, JGS, CEM, CGZ, JJE Dated: February 27, 2013 Received: March 5, 2013

Dear Dr. Katz:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Page 2—Dr. Katz

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to   
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours,

# Carol C. Benson -S for

Courtney H. Lias, Ph.D.   
Director   
Division of Chemistry and Toxicology Devices Office of In Vitro Diagnostics   
and Radiological Health   
Center for Devices and Radiological Health

Enclosure

# Indications for Use

510(k) Number (if known): k123018

Device Name: ACE Alera Clinical Chemistry System, ACE Glucose Reagent, ACE Ion Selective Electrode (ISE) Module

Indications for Use:

The ACE Alera Clinical Chemistry System is an automated, discrete, bench-top, random access analyzer that is intended for in vitro diagnostic use in the quantitative measurement of general chemistry assays, such as glucose, sodium, potassium, and chloride, for clinical use in physician office laboratories or clinical laboratories.

• Glucose measurements are used in the diagnosis and treatment of carbohydrate metabolism disorders including diabetes mellitus, neonatal hypoglycemia, and idiopathic hypoglycemia, and of pancreatic islet cell carcinoma. Sodium measurements are used in the diagnosis and treatment of diseases involving electrolyte imbalance. D Potassium measurements are used to monitor electrolyte balance in the diagnosis and treatment of disease conditions characterized by low or high blood potassium levels. • Chloride measurements are used in the diagnosis and treatment of electrolyte and metabolic disorders such as cystic fibrosis and diabetic acidosis.

ACE Glucose Reagent is intended for the quantitative determination of glucose in serum and lithium heparin plasma using the ACE, ACE Alera, and ACE Axcel Clinical Chemistry Systems. Glucose measurements are used in the diagnosis and treatment of carbohydrate metabolism disorders including diabetes mellitus, neonatal hypoglycemia, and idiopathic hypoglycemia, and of pancreatic islet cell carcinoma. This test is intended for use in clinical laboratories and physician office laboratories. For in vitro diagnostic use only.

AND/OR

Prescription Use X (21 CFR Part 801 Subpart D)

Over-The-Counter Use. (21 CFR Part 801 Subpart C)

# Indications for Use

The ACE Ion Selective Electrode (ISE) module on the ACE, ACE Alera, and ACE Axcel Clinical Chemistry Systems is used to measure concentrations of sodium, potassium, and chloride in undiluted serum and lithium heparin plasma.

Sodium measurements are used in the diagnosis and treatment of diseases involving electrolyte imbalance. Potassium measurements are used to monitor electrolyte balance in the diagnosis and treatment of disease conditions characterized by low or high blood potassium levels. • Chloride measurements are used in the diagnosis and treatment of electrolyte and metabolic disorders such as cystic fibrosis and diabetic acidosis.

This tst s intended or use n clinical laboratories and physician offe aboratorie. For in vitro diagnostic use only.

# Concurrence of CDRH, Offce of In Vitro Devices or Radiological Health (OIR)